Authors:
MERISKOLIVERSIDGE E
SARPOTDAR P
BRUNO J
HAJJ S
WEI L
PELTIER N
RAKE J
SHAW JM
PUGH S
POLIN L
JONES J
CORBETT T
COOPER E
LIVERSIDGE GG
Citation: E. Meriskoliversidge et al., FORMULATION AND ANTITUMOR-ACTIVITY EVALUATION OF NANOCRYSTALLINE SUSPENSIONS OF POORLY SOLUBLE ANTICANCER DRUGS, Pharmaceutical research, 13(2), 1996, pp. 272-278
Citation: Bv. Huff et al., THE ELECTROPHORETIC MOBILITY OF TRIPEPTIDES AS A FUNCTION OF PH AND IONIC-STRENGTH - COMPARISON WITH IONTOPHORETIC FLUX DATA, Pharmaceutical research, 12(5), 1995, pp. 751-755
Citation: Gg. Liversidge et P. Conzentino, DRUG PARTICLE-SIZE REDUCTION FOR DECREASING GASTRIC IRRITANCY AND ENHANCING ABSORPTION OF NAPROXEN IN RATS, International journal of pharmaceutics, 125(2), 1995, pp. 309-313
Citation: Gg. Liversidge et Kc. Cundy, PARTICLE-SIZE REDUCTION FOR IMPROVEMENT OF ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS .1. ABSOLUTE ORAL BIOAVAILABILITY OF NANOCRYSTALLINE DANAZOL IN BEAGLE DOGS, International journal of pharmaceutics, 125(1), 1995, pp. 91-97